Keywords: Market forecasts, Asthma, COPD, Transparency Market Research

Global asthma and COPD drug market to reach nearly $27 billion in 2017

Article | 19 June 2012

The global asthma and chronic obstructive pulmonary disease (COPD) market was worth $25.102 billion in 2010, and is expected to reach $26.965 billion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in